India's Eris Lifesciences gains on quarterly profit climb
** Shares of Eris Lifesciences ERIS.NS rise 2.6% to 1,481 rupees ** Drugmaker reports 32% Y/Y rise in Q4 consol net profit to 937.4 mln rupees ($11 million), rev from ops grew 28% Y/Y ** Stock rated "buy" on avg; median PT is 1,595 rupees, per data compiled by LSEG ** Stock up 11.3% YTD ($1 = 85.4380 Indian rupees) (Reporting by Rudra Pratap Singh in Bengaluru) ((rudrapratap.singh@thomsonreuters.com))
Recent news on Eris Lifesciences
See all newsIndia's Eris Lifesciences gains on strong quarterly results
Brief: Eris Lifesciences Sept-Quarter Consol Net Profit 1.84 Billion Rupees
Brief: Eris Lifesciences Says Krishnakumar Vaidyanathan Resigns As Executive Director & COO
Brief: Eris Lifesciences Ltd Says June-Quarter Consol Net Profit 1.42 Billion Rupees
Brief: Eris Lifesciences March-Quarter Consol Net Profit 2.82 Billion Rupees